Novostia raised CHF 5.6 million in a Series B funding round to accelerate clinical studies and development efforts.
Amount Raised
CHF5.6 Million
Round Type
Series B
LausanneManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
Novostia has successfully completed a CHF 5.6 million fundraising to advance its clinical evidence base for its heart valve prosthesis. This funding will help in accelerating ongoing development efforts and preparing for the next financial round.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Novostia that raised within 45 days of this round, from Fundz verified event records.
- Nusano raised $115M (Series C) on October 1, 2024.
- PanTera raised $103M (Series A) on September 11, 2024.
- Neochord raised $914K (Seed) on August 16, 2024.
- Revolution-ZERO raised $321K (Funding Round) on August 16, 2024.
- Aevice Health raised $7M (Seed) on August 12, 2024.
- Xtant Medical Holdings raised $5M on August 9, 2024.
Who to call at Novostia, and when
A new round usually means Novostia is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Novostia raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novostia, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novostia. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novostia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNovostia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.